Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human CPD Anticorps:
anti-Mouse (Murine) CPD Anticorps:
anti-Rat (Rattus) CPD Anticorps:
Vous arrivez à notre recherche pré-filtrée.
prolactin induction of VEGF-C and Runx2 was inhibited partly by Carboxypeptidase-D inhibitors, implicating nitric oxide , produced by PRL-regulated Carboxypeptidase-D, in breast cancer progression
Carboxypeptidase-D (CPD) overexpression coincides with high-grade lung cancer and the CPD overexpression could reverse the inhibitory effects of miR (Montrer MLXIP Anticorps)-214
The human carboxypeptidase D transthyretin (Montrer TTR Anticorps)-like domain forms amyloid under physiological conditions.
Prolactin (Montrer PRL Anticorps) and R1881, acting through Stat5 (Montrer STAT5A Anticorps) and androgen receptor (Montrer AR Anticorps), act cooperatively to stimulate CPD gene transcription in breast cancer cells.
CPD immunostaining and testosterone/prolactin (Montrer PRL Anticorps)-stimulated CPD expression were higher in prostate cancer than benign tissues/cells. Elevated CPD increased NO production, which was abolished when both androgen and prolactin (Montrer PRL Anticorps) receptors were inhibited.
Carboxypeptidase D (CPD) is frequently upregulated in hepatocellular carcinoma; targeting CPD inhibits hepatocellular carcinoma cell proliferation through induction of G1 cell-cycle arrest and apoptosis.
Either high glucose or insulin (Montrer INS Anticorps) (with low glucose) up-regulates beta-cell CPD (but not CPE (Montrer CPE Anticorps)).
Palmitoylation of carboxypeptidase D has a role in intracellular trafficking
The isolation and characterization of CPD from several haematopoietic tumour cells are reported.
First report to demonstrate carboxypeptidase D as part of the transforming growth factor (TGF)-beta (Montrer TGFB1 Anticorps) pathway as a TGF-beta (Montrer TGFB1 Anticorps) target gene implicated in the pathogenesis of lupus erythematosus.
CPD localization to the TGN (Montrer TG Anticorps) requires both static retention involving the C-terminal domain and phosphorylation at a CK2 (Montrer CSNK2A1 Anticorps) site, which regulates the binding of adaptor proteins.
The carboxypeptidase D homolog silver regulates memory formation via insulin (Montrer INS Anticorps) pathway in Drosophila.(
Individual carboxypeptidase D domains have both redundant and unique functions in Drosophila development and behavior.
the Drosophila silver gene corresponds to a Carboxypeptidase D-like protein with three carboxypeptidase-like domains, a transmembrane domain, and a cytosolic tail
The molecular basis for the phenotype of 3 carboxypeptidase D mutations are presented.
Data show that Drosophila S2 cells produce multiple forms of carboxypeptidase D with different intracellular distributions.
The metallocarboxypeptidase family of enzymes is divided into 2 subfamilies based on sequence similarities. The pancreatic carboxypeptidase-like and the regulatory B-type carboxypeptidase subfamilies. Carboxypeptidase D has been identified as a regulatory B-type carboxypeptidase. CPD is a homolog of duck gp180, a hepatitis B virus-binding protein. Transcript variants utilizing alternative polyadenylation signals exist for this gene.
, carboxypeptidase D
, carboxypeptidase E